Pain · 2001 · 59 citations · 48 references
MedicinePharmacologyNeuropharmacologyPain MedicinePharmacodynamicsAnalgesiaAnalgesic PharmacologyOpioid AnalgesicsOpioid PharmacologyPain ModulationPharmacologic Pain TherapyAgonist ActivityAnalgesic EffectsCalcium Channel ModulatorsDelta Opioid Receptor PharmacologyDose ResponseKappa Opioid Receptor PharmacologyOpioid Receptor AgonistsPain Pharmacology
We examined the effects of amlodipine, a selective L-type voltage dependent Ca(2+) channel (VDCC) blocker, and mibefradil, a selective T-type VDCC blocker on the antinociceptive effects of morphine, and mu, delta and kappa opioid receptor selective agonist-induced antinociception at the spinal level. Intrathecally administered amlodipine and mibefradil potentiated morphine and [D-Ala(2), N mePhe(4), Gly-ol(5)] enkephalin (DAMGO)-induced antinociception by shifting their dose response curves to the left. However, intrathecally administered amlodipine and mibefradil did not affect [D-Pen(2), D-Pen(5)]enkephalin (DPDPE) and [trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrolidinyl)cyclohexyl] benzene acetamide (U-50, 488H)-induced antinociception. These data indicate that L-type and T-type VDCC blockers synergistically potentiate the analgesic effects of mu opioid receptor agonists, but not delta and kappa opioid receptor agonists, at the spinal level. Additionally, these data suggest that there is an important functional interaction between L-type and/ or T-type VDCC and mu opioid receptors in the process of analgesia.
48
Intrathecal morphine in mice: A new technique
Janice L.K. Hylden, George L. Wilcox · European Journal of Pharmacology · 1980 · 1.9K citations
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo
Tony L. Yaksh, Thomas M. Jessell, R. Gamse et al. · Nature · 1980 · 697 citations
Medicine, Neuroscience, Pharmacology +12